Brief overview of proven therapeutic uses for CBD Oil
Analgesic – Relieves pain.
Antibacterial – Slows bacterial growth.
Anti-Diabetic – CBD is the only cannabinoid identified that helps lower blood sugar levels.
Antidepressant – Relieves symptoms of depression.
Anti-Emetic – Reduces vomiting and nausea.
Anti-Epileptic – Reduces seizures and convulsions.
Anti-inflammatory – Reduces inflammation systemically.
Anti-Insomnia – Aids with sleep.
Anti-Ischemic – CBD is the only cannabinoid identified that reduces the risk of artery blockage.
Antipsioratic – CBD is the only cannabinoid identified to treat psoriasis.
Anti-Proliferative – Inhibits cancer cell growth.
Antipsychotic – Tranquilizing effects to relieve symptoms of psychosis, two terpenoids (linalool and myrcene) also help.
Antioxidant – Prevents the damage of oxidation to other molecules in the body.
Antispasmodic – Suppresses muscle spasms.
Anxiolitic – CBD is the only cannabinoid identified that relieves anxiety, but two terpenoids also help (linalool and limonene).
Bone Stimulant – Promotes bone growth.
Immunosuppressive – CBD is the only cannabinoid identified that reduces function in the immune system.
Intestinal Anti-Prokinetic – CBD is the only cannabinoid identified that reduces small intestine contractions.
Neuroprotective – Slows damage to the nervous system and brain.
Vasorelaxant– CBD is the only cannabinoid identified that reduces vascular tension.
CBD is also currently being studied for a variety of conditions including:
Alzheimer’s Disease/Dementia/Memory Loss: CBD’s strong neuroprotective and antioxidative effects work together to counteract the effects of aging on our brains, fighting off memory loss and dementia.
Bone Healing: New research from March 2015 has shown that CBD’s ability to stimulate bone growth is powerful enough to speed up and enhance the healing of broken bones. The same study found that THC had a related role in the healing of broken bones, working in entourage with CBD.
Cancer: A study was published in 2007, regarding ongoing research being done at San Francisco’s California Pacific Medical Center, showing that CBD inhibits a particular gene (Id-1) which is responsible for the growth of cancer cells in the body. By inhibiting this gene CBD shuts down the growth of cancer cells, potentially stopping or even reversing tumor growth. While it is premature to say that CBD cures cancer, it is worth further research.
Dravet Syndrome/Epilepsy: In October of 2013, the Food and Drug Administration (FDA) approved two clinical trials assessing the therapeutic uses of CBD in treating intractable epilepsy in children. The CBD preparations are being made by British pharmaceutical company GW Pharmaceuticals, makers of Sativex. Dravet is a rare seizure disorder where usually children will have their first intractable seizure before they are even one year old, and in exceptional cases seizures can last over 24 hours. Harborside, where I work, has a famous patient named Jayden, a young boy who uses a CBD-rich tincture to treat his Dravet Syndrome.
Depression/Anxiety: CBD stimulates the 5-HT1a receptor in the brain, a region involved in the re-uptake of serotonin and other processes that aid with depression and anxiety. The antidepressant properties of CBD are very similar to the trycyclic antidepressant Imipramine (also being evaluated for panic disorder).
Diabetes: CBD was first discovered to mitigate the effects of diabetes in 2006. since then it has been shown to have numerous benefits for people with diabetes, specifically in reducing neurotoxicity and inflammation. In a follow up study done in 2010, it was found that CBD worked as a defense against neurodegeneration. Another 2010 study said CBD had “great therapeutic potential in the treatment of diabetic complications, and perhaps other cardiovascular disorders.”
Inflammatory Bowel Disease/Crohn’s Disease: CBD shows a lot of promise for controlling the inflammatory responses and discomfort caused by Crohn’s disease and IBD. CBD has so much potential to regulate these diseases that it is being considered for a new class of IBD drugs.
Nausea: In a study done on nausea and vomiting, CBD was shown to have anti-emetic, anti-nausea effects. The same study found that CBG could block these anti-nausea effects, perhaps because moderate doses of CBD and CBG may oppose eachother at the 5HTP1a receptor in the brain.
Schizophrenia/Psychosis: CBD is a powerful antipsychotic currently being considered for use in treating schizophrenia and other psychoses. Cannabidiol appears to have a very similar chemical profile to certain atypical antipsychotic drugs.